Search details
1.
The cost-effectiveness of dacomitinib in first-line treatment of advanced/metastatic epidermal growth factor receptor mutation-positive non-small-cell lung cancer (EGFRm NSCLC) in Sweden.
J Med Econ
; 24(1): 447-457, 2021.
Article
in English
| MEDLINE | ID: mdl-33754924
2.
Cost-effectiveness of carfilzomib plus dexamethasone compared with bortezomib plus dexamethasone for patients with relapsed or refractory multiple myeloma in the United States.
Expert Rev Hematol
; 10(12): 1107-1119, 2017 12.
Article
in English
| MEDLINE | ID: mdl-29027825
3.
Cost-effectiveness of adding carfilzomib to lenalidomide and dexamethasone in relapsed multiple myeloma from a US perspective.
J Med Econ
; 19(11): 1061-1074, 2016 Nov.
Article
in English
| MEDLINE | ID: mdl-27224006
4.
Optimizing early detection of avian influenza H5N1 in backyard and free-range poultry production systems in Thailand.
Prev Vet Med
; 105(3): 223-34, 2012 Jul 01.
Article
in English
| MEDLINE | ID: mdl-22296731
Results
1 -
4
de 4
1
Next >
>>